Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tuberculosis
|
328 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Thyroid Neoplasm
|
135 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||
Thyroid carcinoma
|
145 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.040 | 1.000 | 4 | 2016 | 2019 | |||||
Thrombocythemia, Essential
|
37 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.030 | 1.000 | 3 | 2015 | 2018 | |||||
Testicular Neoplasms
|
31 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||
Testicular Germ Cell Tumor
|
93 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.800 | 1.000 | 3 | 2013 | 2017 | |||||
Stomach Carcinoma
|
652 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.030 | 1.000 | 3 | 2015 | 2017 | |||||
Squamous cell carcinoma of the head and neck
|
348 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Squamous cell carcinoma
|
257 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.020 | 1.000 | 2 | 2009 | 2010 | |||||
Solid Neoplasm
|
24 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Renal Cell Carcinoma
|
288 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.010 | 1 | 2019 | 2019 | ||||||
Red Blood Cell Count measurement
|
1599 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||
Prostate carcinoma
|
1168 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.020 | 1.000 | 2 | 2015 | 2015 | |||||
Primary malignant neoplasm of lung
|
981 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.100 | 1.000 | 18 | 2010 | 2015 | |||||
Primary malignant neoplasm
|
1374 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.070 | 1.000 | 7 | 2012 | 2018 | |||||
Post-Traumatic Stress Disorder
|
117 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Polycythemia Vera
|
38 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.030 | 1.000 | 3 | 2015 | 2018 | |||||
Platelet Count measurement
|
457 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.700 | 1.000 | 2 | 2016 | 2018 | |||||
Piebaldism
|
18 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Papillary thyroid carcinoma
|
204 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||
Pancreatic carcinoma
|
322 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.060 | 1.000 | 6 | 2009 | 2016 | |||||
Nicotine Dependence
|
178 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Neoplasms
|
1644 | 0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 | 0.070 | 1.000 | 7 | 2010 | 2017 |